Skip to main content
SpringerPlus
Scheme 1 | SpringerPlus

Scheme 1

From: Discovery of the molecular mechanisms of the novel chalcone-based Magnaporthe oryzae inhibitor C1 using transcriptomic profiling and co-expression network analysis

Scheme 1

Flowchart of the methods. The scheme includes three steps. Firstly, differentially expressed mRNAs in drug-treated M. oryzae compared with the control group were identified via microarray analysis. Then, bioinformatics analysis, including GO and KEGG pathway enrichment, inverse docking and WGCNA network, were performed for speculating the correlation between potential targets and DEGs. Subsequently, we utilized qRT-PCR and Western blot to validate the microarray results

Back to article page